Clinical Trials Directory

Trials / Completed

CompletedNCT06927700

Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,257 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModified Risk Claim Type - NoneParticipants will view smokeless tobacco ads with no modified risk claim (control)
BEHAVIORALProduct Brand - General SnusParticipants will views ads for the smokeless tobacco brand General Snus
BEHAVIORALProduct Brand - CopenhagenParticipants will views ads for the smokeless tobacco brand Copenhagen
BEHAVIORALModified Risk Claim Type - Multiple DiseasesParticipants will view smokeless tobacco ads with a claim about lower risks for multiple diseases
BEHAVIORALModified Risk Claim Type - Lung CancerParticipants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only

Timeline

Start date
2025-04-24
Primary completion
2025-05-04
Completion
2025-05-04
First posted
2025-04-15
Last updated
2026-03-04
Results posted
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06927700. Inclusion in this directory is not an endorsement.